The agency has expanded the use of Alyftrek and Trikafta for treating patients with any genetic variant that results in production of CFTR proteins.

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of ...

Vertex Pharmaceuticals (VRTX) stock is in focus as the FDA greenlights label expansions for its cystic fibrosis drugs, ...

Agena Bioscience, a global provider of molecular genomics solutions, recently announced the launch of the CFTR 100+ Panel, a multiplex genotyping solution designed to provide expanded coverage of CFTR ...

Current newborn screening for cystic fibrosis favors white children over those from other backgrounds CF genetic screens typically use one variant that’s found predominantly in people of European ...

Twenty years ago, cystic fibrosis wasn’t a household term for me. Today, cystic fibrosis — a genetic disorder that causes a buildup of thick, sticky mucus that can damage organs, especially the lungs ...

States screen for cystic fibrosis (CF) but with significant variation among their screening algorithms. The Cystic Fibrosis Foundation group conducted a systematic review, leading to seven ...

Until you read this, you weren’t thinking about your breathing (sorry I mentioned it). But now that you’re paying attention, maybe your breathing has become a little more shallow, its frequency a ...

A genetics team determines that a 59-year-old man referred for multiple colon polyps should also be tested for genes ...

The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...